NCT07421830 An Empowering Parent Training Intervention to Increase Physical Activity in Preschool Aged Children With Autism
| NCT ID | NCT07421830 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northeastern University |
| Condition | Autism Spectrum Disorder (ASD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 114 participants |
| Start Date | 2026-02-20 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 114 participants in total. It began in 2026-02-20 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if WE PLAY for Parents can improve caregivers' knowledge, attitudes, confidence, and skills promoting physical activity with their young child with autism. The main questions it aims to answer are: (1) Do participants who complete WE PLAY for Parents improve their knowledge, behavior intentions, perceived behavior control, self-efficacy, and parenting practices related to physical activity promotion with their child (Primary Hypotheses); and (2) Do participants view WE PLAY for Parents as acceptable, understandable, and feasible \[secondary hypothesis)? Researchers will compare the WE PLAY for Parents group \[experimental arm\] to a Waitlist Control group to see if there are differences in the variables listed in the primary hypothesis. Participants will: (1) Complete a set of questionnaires at three timepoints: pre-training, post-training, and 3-month follow-up that each take between 10-15 minutes; (2) be randomly assigned to take the training over the next two weeks or be offered the training after 3 months. The online training takes about 90 minutes. It includes watching informational videos, viewing video clips of adults helping children be active, reading handouts on behavior management tips and social stories, participating in an anonymous discussion board with other parents, and completing a self-assessment.
Eligibility Criteria
Inclusion Criteria: * Parents or caregivers (who are at least 18 years of age) of children with a diagnosis of autism. * The autism diagnosis for the child can be from a school or medical setting. * The parent or caregiver's child with autism must be between 2 years 11 months and 5 years, 11 months of age. * Parent or caregivers must be able to read and write in English. Exclusion Criteria: * Parents or caregivers who do not have a child with autism. * Adults who do not have children. * Parents or caregivers who cannot read and write in English.
Contact & Investigator
Jessica Hoffman, PhD, NCSP
PRINCIPAL INVESTIGATOR
Northeastern University
Frequently Asked Questions
Who can join the NCT07421830 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Autism Spectrum Disorder (ASD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07421830 currently recruiting?
Yes, NCT07421830 is actively recruiting participants. Contact the research team at medeiros.ha@northeastern.edu for enrollment information.
Where is the NCT07421830 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT07421830 clinical trial?
NCT07421830 is sponsored by Northeastern University. The principal investigator is Jessica Hoffman, PhD, NCSP at Northeastern University. The trial plans to enroll 114 participants.